Current Science

Open Access Open Access  Restricted Access Subscription Access

Antimicrobial Resistance and Phage Therapy in the Indian Context


Affiliations
1 Indian Institute of Science, Bengaluru 560 012, India
 

The discovery of antibiotics was a turning point in the history of mankind, improving healthcare and increasing life expectancy around the globe. However, the rising number of cases of antibiotic-resistant infections paints a concerning future. Thus, it is essential to understand and explore alternatives and implement policies for their safe usage. This note summarizes the upsurge in antimicrobial resistance in recent years and the feasibility of phage therapy as an alternative in India.
User
Notifications
Font Size

  • WHO, Antimicrobial resistance: global report on surveillance. World Health Organization, Geneva, 2014.

  • DBT (with Research Councils United Kingdom). Scoping report on antimicrobial resistance in India, Department of Biotechnology, Government of India (GoI), 2017.

  • Laxminarayan, R. et al., Lancet Infect. Dis., 2013, 13(12), 1057–1098.

  • Center for Disease Dynamics, Economics and Policy, 2015, State of the World’s Antibiotics, Washington DC, USA, 2015; https://www.cddep.org/wpcontent/uploads/2017/06/swa_edits_9.16.pdf

  • Dhawde, R. et al., Int. J. Environ. Res. Public Health, 2018, 15(6), 1247.

  • Devarajan, N. et al., PLoS ONE, 2016, 11(2), e0149211.

  • Ministry of Health and Family Welfare, National Action Plan on Antimicrobial Resistance (NAP AMR) 2017–21, GoI, 2016.

  • Walia, K., Ohri, V. C. and Mathai, D., Indian J. Med. Res., 2015, 142(2), 130.

  • Kakkar, M. et al., BMJ, 2017, 358, j2687.

  • Laxminarayan, R. and Chaudhury, R. R., PLoS Med., 2016, 13(3), e1001974.

  • McGettigan, P. et al., Br. J. Clin. Pharmacol., 2018, 85, 59–70.

  • Van Boeckel et al., Proc. Natl. Acad. Sci., 2015, 112(18), 5649–5654.

  • Ahammad, Z. S. et al., Environ. Sci. Technol., 2014, 48(5), 3014–3020.

  • Weber-Dąbrowska et al., In Inflammation (eds Górski, A., Krotkiewski, H. and Zimecki, M.), Springer, Dordrecht, 2001, pp. 201–209; PMID:11197610.

  • Hankin, E. H., Ann. Inst. Pasteur., 1896, 10(5), 2.

  • Regulations and Guidelines. Indian Pharmaceutical Association, Crusade for the profession, Daffodil Design and Prints; https://ipapharma.org/portfolio/regulationsand-guidelines

  • Expert Round Table on Acceptance and Re-Implementation of Bacteriophage Therapy. Biotechnol. J., 2016, 11(5), 595–600.

  • Dixit, A. et al., Indian J. Community Med., 2019, 44(1), 4.


Abstract Views: 403

PDF Views: 112




  • Antimicrobial Resistance and Phage Therapy in the Indian Context

Abstract Views: 403  |  PDF Views: 112

Authors

Gopika Ranjith
Indian Institute of Science, Bengaluru 560 012, India
Aditi Ajith Pujar
Indian Institute of Science, Bengaluru 560 012, India
Ashim Kumar Dubey
Indian Institute of Science, Bengaluru 560 012, India
Preetham Venkatesh
Indian Institute of Science, Bengaluru 560 012, India

Abstract


The discovery of antibiotics was a turning point in the history of mankind, improving healthcare and increasing life expectancy around the globe. However, the rising number of cases of antibiotic-resistant infections paints a concerning future. Thus, it is essential to understand and explore alternatives and implement policies for their safe usage. This note summarizes the upsurge in antimicrobial resistance in recent years and the feasibility of phage therapy as an alternative in India.

References





DOI: https://doi.org/10.18520/cs%2Fv117%2Fi4%2F562-564